Branded and compounded weight-loss medications: understanding the difference

Start with the finished product

One ingredient name can describe very different products.

An FDA-approved medication may be a brand-name product or an FDA-approved generic. Before it is marketed, FDA reviews evidence about the finished product's safety and effectiveness and evaluates its manufacturing quality. A compounded medication is prepared for a permitted medical need under a different legal pathway. The finished compounded product is not FDA-approved, and FDA does not review it for safety, effectiveness, or quality before it reaches patients.¹

That does not mean every compounded medication is unsafe. Pharmacy compounding is a legitimate and longstanding part of medicine and can meet an important need when an approved product cannot meet a particular patient's needs or is not commercially available. It does mean the products should not be presented as interchangeable.²

The prescription decision should begin with your health history and a clear clinical reason—not with a price, social-media promotion, or product selected before a physician evaluates you.

Two regulated pathways

A practical comparison

Understanding federal terminology

“503A” and “503B” describe compounders—not levels of FDA approval.

FDA cautions telehealth companies against saying that a compounded drug comes from an “FDA-approved” or “FDA-licensed” pharmacy or outsourcing facility. FDA does not approve or license facilities. A pharmacy may be licensed by a state, and a 503B outsourcing facility is registered with FDA, but neither status means that the facility—or its compounded medications—is FDA-approved.⁵

Rules can change

Drug shortages can change what may be compounded.

Federal law limits routine compounding of products that are essentially copies of commercially available or FDA-approved drugs. When an approved drug appears on FDA's shortage list, certain copy restrictions may not apply if all other legal conditions are met. That flexibility is temporary—not permanent authorization to mass-produce a lower-priced copy.⁶

National shortage status and local pharmacy inventory are not the same. When a shortage ends, a compounder generally cannot continue routine copy production on the same shortage basis. Limited patient-specific compounding may still be permitted when a prescriber documents that a change creates a significant difference for an identified patient and all other requirements are met.⁶

Lawfulness and appropriateness depend on the medication, documented medical need, formulation, compounder, destination state, and rules in effect at the time. This dated article is not a substitute for a current regulatory check.

Quality questions are clinical questions

Every ingredient in the formula should have a reason.

A compounded injectable may contain the prescribed active medication plus one or more added ingredients. Adding something changes the formula. It should be treated as a clinical decision—not as a harmless upgrade, a marketing bonus, or an automatic reason to choose one product over another.

A biological role is not proof of a treatment claim

Some of these ingredients have appropriate uses for a diagnosed deficiency or another specific condition. That does not prove that adding one to a weight-loss medication will increase metabolism, improve weight loss, prevent nausea, boost energy, or make treatment safer for every patient. Evidence about an ingredient by itself also does not automatically validate the exact dose, route, or combined injectable formula being offered.

For example, NIH notes that vitamin B12 does not appear to improve energy or endurance in people who already have adequate B12 status, and evidence for L-carnitine as a weight-loss supplement is mixed.^8,9Higher or duplicative exposure matters too: vitamin B6 can cause nerve injury at excessive sustained doses, and niacinamide can cause adverse effects at high doses. Your total exposure from medications, injections, vitamins, and supplements should be reviewed together.^10,11

Some compounded products include added ingredients, such as vitamin B12 or amino acids. These combinations may not have been studied with the active medication for safety, effectiveness, stability, or compatibility. Talk with Dr. Olson before starting a compounded product so you understand what is included, why it is there, and how it fits with the rest of your plan.¹⁷

The form of the active ingredient matters

FDA-approved semaglutide products use a specific form of the ingredient called the base form. Some compounded versions use a salt form—such as semaglutide sodium or semaglutide acetate—which FDA considers a different active ingredient, not an interchangeable substitute.¹² USP does not currently publish a semaglutide drug-substance monograph that provides one public specification for the ingredient.¹⁷

FDA states that retatrutide and cagrilintide cannot be used in compounding under federal law. Neither is a component of an FDA-approved drug, and neither has been found safe and effective for any condition. FDA has also warned consumers about unapproved retatrutide sold for human use under labels such as “research use only” or “not for human consumption.”¹²

Shipping and storage matter

Injectable products that require refrigeration can lose quality outside the appropriate temperature range. If a package is warm, damaged, leaking, unlabeled, unusually late, or different from what you expected, set it aside and contact the dispensing pharmacy and your prescriber before using it.¹²

Know what you are buying

Compounded, counterfeit, and illegally marketed are not the same.

A legitimate compounded medication is prepared by an appropriately licensed or registered compounder under applicable law. A counterfeit product fraudulently claims to be something it is not. An illegally marketed product may be sold without the required prescription or through an unlicensed source.¹³

FDA has identified fraudulent products marketed as compounded semaglutide or tirzepatide in the United States, including products whose labels named pharmacies that did not exist or licensed pharmacies that had not made them. The safer route is a prescription from a clinician who knows your history, filled by a pharmacy whose license and regulatory record can be verified.^12,13

How Olson Medical would review a pharmacy

Quality review should be documented—not assumed.

The American Diabetes Association has identified concerns involving ingredient form, formulation variability, dosing, added ingredients, and quality oversight. These concerns inform the pharmacy-review process below.¹⁷

If Dr. Olson determines that a compounded medication is medically appropriate and legally available for a particular patient, the pharmacy would not be selected on marketing language or price alone. The review would include, as applicable:

• Active licensure and permits required to dispense or ship into the patient's state
• 503A status or current 503B registration, as applicable
• Available inspection, warning-letter, recall, and disciplinary history
• The active ingredient, its source, supplier controls, and available certificates of analysis—recognizing that a certificate alone does not validate the finished drug or sterile process
• Appropriate finished-formula identity, potency, sterility, endotoxin, compatibility, stability, and beyond-use-date support, including independent laboratory information when applicable
• Lot traceability, beyond-use dating, labeling, recall procedures, packaging, and temperature controls
• A reachable pharmacist and a clear process for quality concerns or adverse events

Why the review matters

Not every sterile compounder has the same record or safeguards.

FDA records have documented visible particulate, use of nonsterile ingredients without a sterilization step, microbial-control deficiencies, and injectable products with out-of-specification strength. Those findings do not mean that every compounded medication is unsafe. They show why a polished website, familiar pharmacy name, or low price cannot replace a documented review.^14,15,16

See three documented examples

• Fullerton Wellness · 2024 FDA alert: FDA received a complaint about black particulate in compounded semaglutide and later observed nonsterile ingredients being used for injectable drugs without a sterilization step. The facility had voluntarily ceased operations after a state inspection.¹⁴
• Empower Pharma · 2025 FDA warning letter: FDA described microbial-control deficiencies and acknowledged a pyridoxine (B6) injection recall for lack of sterility assurance.¹⁵
• Olympia Pharmacy · 2022 voluntary recall: injectable lots that included NAD and hydroxocobalamin were recalled after out-of-specification results created a risk of too much or too little active ingredient.¹⁶

This review can reduce avoidable risk. It cannot turn a compounded drug into an FDA-approved product, prove it will work exactly like an approved product, or guarantee that every dose will be free of a defect. Olson Medical would not use a pharmacy whose documentation, licensure, product identity, or shipping process is unsatisfactory.

Medication, dispensing, pharmacy shipping, and laboratory charges are separate from Olson Medical membership and professional fees. A lower price is never a substitute for a medically appropriate plan and transparent quality review.

Questions worth asking

Before you start a medication

• Is the finished product FDA-approved or compounded?
• If compounded, what patient-specific medical need does it address for me?
• Who will make and dispense it, and may that pharmacy ship to my state?
• What is the exact active ingredient, concentration, dose, and measuring instruction?
• What else is mixed into the formula, why is it included, and what evidence supports that use for me?
• What quality documentation is available for the product?
• How should it be shipped and stored, and what if it arrives warm or damaged?
• Who should I contact about a missed dose, side effect, treatment break, or health change?
• Which medication and pharmacy charges are separate from medical membership?